Highly emetogenic cancer chemotherapy (MEC)
Also known as: Highly emetogenic chemotherapy / Highly emetogenic cancer chemotherapy
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00904 | Ondansetron | A serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting in cancer chemotherapy and postoperatively. |
| DB00377 | Palonosetron | A serotonin antagonist used in the prophylaxis or management of vomiting that results from emetogenic chemotherapy, and for the management of postoperative nausea and vomiting. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01234 | Dexamethasone | 3 | Not Yet Recruiting | 1 |
| DB09048 | Netupitant | 3 | Not Yet Recruiting | 1 |
| DB00334 | Olanzapine | 3 | Not Yet Recruiting | 1 |
| DB00377 | Palonosetron | 3 | Not Yet Recruiting | 1 |